ACE and metabolic dysfunction-associated steatotic liver disease: Knowledge of the ACE level and ACE gene polymorphism in patients with NAFLD/nonalcoholic steatohepatitis (NASH) may be beneficial in terms of determining the treatment methods and in the follow-up of the disease progression.